Cited by 7Treatment of Major DepressionSuicide and Self-Harm StudiesElectroconvulsive Therapy Studies

Suicide prevention and ketamine: insights from computational modeling

Open access
Charlton, Colleen E., Karvelis, Povilas, McIntyre, Roger S., Diaconescu, Andreea O.·2023·Frontiers in Psychiatry

Abstract

Suicide is a pressing public health issue, with over 700,000 individuals dying each year. Ketamine has emerged as a promising treatment for suicidal thoughts and behaviors (STBs), yet the complex mechanisms underlying ketamine’s anti-suicidal effect are not fully understood. Computational psychiatry provides a promising framework for exploring the dynamic interactions underlying suicidality and ketamine’s therapeutic action, offering insight into potential biomarkers, treatment targets, and the underlying mechanisms of both. This paper provides an overview of current computational theories of suicidality and ketamine’s mechanism of action, and discusses various computational modeling approaches that attempt to explain ketamine’s anti-suicidal effect. More specifically, the therapeutic potential of ketamine is explored in the context of the mismatch negativity and the predictive coding framework, by considering neurocircuits involved in learning and decision-making, and investigating altered connectivity strengths and receptor densities targeted by ketamine. Theory-driven computational models offer a promising approach to integrate existing knowledge of suicidality and ketamine, and for the extraction of model-derived mechanistic parameters that can be used to identify patient subgroups and personalized treatment approaches. Future computational studies on ketamine’s mechanism of action should optimize task design and modeling approaches to ensure parameter reliability, and external factors such as set and setting, as well as psychedelic-assisted therapy should be evaluated for their additional therapeutic value.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2023.1214018

Cites

145 of 146 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pharmacological approaches, particularly rapid-acting agents (i.e., ketamine), have attracted growing attention due to their capacity to produce short-term reductions in depressive symptoms, suicidal ideation, and affective distress.

    “Pharmacological approaches, particularly rapid-acting agents (i.e., ketamine), have attracted growing attention due to their capacity to produce short-term reductions in depressive symptoms, suicidal ideation, and affective distress [75,76,77].”

    From Targeting Psychological Pain After a Suicide Attempt: Scoping Review and Intervention Protocol (2026) · cites this paper as [77]

    The Introduction reports that ketamine relieves depressive symptoms and reduces suicidal ideation within hours, but that its effect after a single infusion typically abates within a week. It also says these rapid effects have prompted further study. The passages found do not establish a short-term reduction in affective distress as a separate outcome. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 147 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Charlton, C. E., Karvelis, P., McIntyre, R. S., & Diaconescu, A. O.
Affiliations
  • Centre for Addiction and Mental Health (CA)
  • University of Toronto (CA)
Corresponding author
Charlton, Colleen E.
Venue
Frontiers in Psychiatry
Published
2023-06-29
Volume
14
Pages
1214018-1214018
ISSN
1664-0640 (ISSN-L)
OpenAlex
W4382812259
Cited by
7
References
147
Citations by year
2026: 2 · 2025: 1 · 2024: 4
FWCI
0.25
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Krembil Foundation
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
suicide prevention, ketamine, suicidal thoughts and behaviors, computational psychiatry, mismatch negativity, predictive coding, decision-making, neural circuits, receptor density, biomarkers, personalized treatment, psychedelic therapy, set and setting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review